ARCA · PRTO
RCN Pareto Strategic Allocation
$27.17 -$0.08 (-0.29%) 1DKey Metrics
$1.11B
Market cap
—
P/E · TTM
—
Revenue · TTM
−$63.31M
Net income
EPS · TTM
$-1.56
Dividend yield
—
Free cash flow
−$63.09M
Beta · 1Y
—
EBITDA · TTM
−$69.69M
Gross margin
—
Snapshot
Market cap—
Enterprise value—
Shares outstanding—
52-wk range$24.68 – $28.16
Avg volume · 20D1.9K
Net cash
—
Book value / share$4.45
IndustryBiological Products, (No Diagnostic Substances)
ExchangeARCA
About RCN Pareto Strategic Allocation
IPO dateMar 24, 2026
Employees—
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—
Profitability
Gross
—
Operating
—
Net
—
FCF
—
ROE / ROIC
-36.3% · —
Financial Health
Current ratio15.69
Quick ratio—
Debt / equity—
Debt / EBITDA
—
Net cash
—
Working capital$131.08M
Cash Flow · TTM
Operating CF
−$63.00M
Capex
−$94.00K
Free cash flow
−$63.09M
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
1 / 9
Weak fundamentals · 1 of 9 signals passing
Altman Z-Score
—
Insufficient balance-sheet inputs
Graham Number vs Price
—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings